Company Filing History:
Years Active: 2017-2025
Title: Nachman Mazurek: Innovator in Cancer Detection
Introduction
Nachman Mazurek is a prominent inventor based in Houston, TX (US). He has made significant contributions to the field of cancer detection, particularly through his innovative methods for identifying colorectal cancer. With a total of 3 patents to his name, Mazurek's work is paving the way for advancements in medical diagnostics.
Latest Patents
Mazurek's latest patents focus on biomarkers for detecting cancer. One of his notable inventions involves methods for detecting colorectal cancer or precancerous conditions, such as adenomatous polyps. This is achieved by identifying a galactose-containing 40-kDa molecule in serum samples from subjects. Additionally, his methods include quantifying the amount of this molecule and may involve assaying for other markers, such as galectin-3, carcinoembryonic antigen (CEA), and CYFRA21-1, to confirm the diagnosis of colorectal cancer.
Career Highlights
Mazurek is affiliated with the University of Texas System, where he continues to contribute to research and innovation in cancer detection. His work is characterized by a commitment to improving diagnostic methods, which can lead to earlier detection and better patient outcomes.
Collaborations
Mazurek has collaborated with esteemed colleagues, including Robert Bresalier and James C Byrd. These partnerships have enhanced the scope and impact of his research in the medical field.
Conclusion
Nachman Mazurek's innovative work in cancer detection exemplifies the importance of research and development in healthcare. His contributions are vital for advancing diagnostic techniques and improving patient care.